Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Related Citations for PubMed (Select 22700700)

1.

Management of pharyngeal gonorrhea is crucial to prevent the emergence and spread of antibiotic-resistant Neisseria gonorrhoeae.

Deguchi T, Yasuda M, Ito S.

Antimicrob Agents Chemother. 2012 Jul;56(7):4039-40; author re[ply 4041-2. doi: 10.1128/AAC.00505-12. No abstract available.

2.

High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.

Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P.

Antimicrob Agents Chemother. 2012 Mar;56(3):1273-80. doi: 10.1128/AAC.05760-11. Epub 2011 Dec 12.

3.

Phylogenomics for drug-resistant Neisseria gonorrhoeae.

Ohnishi M, Unemo M.

Lancet Infect Dis. 2014 Mar;14(3):179-80. doi: 10.1016/S1473-3099(13)70700-X. Epub 2014 Jan 22. No abstract available.

PMID:
24462210
4.

Preparing for an era of untreatable gonorrhea.

Barbee LA.

Curr Opin Infect Dis. 2014 Jun;27(3):282-7. doi: 10.1097/QCO.0000000000000058. Review.

PMID:
24685549
5.

Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains.

Whiley DM, Jacobsson S, Tapsall JW, Nissen MD, Sloots TP, Unemo M.

J Antimicrob Chemother. 2010 Dec;65(12):2543-7. doi: 10.1093/jac/dkq377. Epub 2010 Oct 12.

6.

Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study.

Grad YH, Kirkcaldy RD, Trees D, Dordel J, Harris SR, Goldstein E, Weinstock H, Parkhill J, Hanage WP, Bentley S, Lipsitch M.

Lancet Infect Dis. 2014 Mar;14(3):220-6. doi: 10.1016/S1473-3099(13)70693-5. Epub 2014 Jan 22.

7.

Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection.

Plourde PJ, Tyndall M, Agoki E, Ombette J, Slaney LA, D'Costa LJ, Ndinya-Achola JO, Plummer FA.

J Infect Dis. 1992 Oct;166(4):919-22.

PMID:
1527431
8.
9.

Antimicrobial resistance in Neisseria gonorrhoeae in the UK: surveillance and management.

Ison CA, Alexander S.

Expert Rev Anti Infect Ther. 2011 Oct;9(10):867-76. doi: 10.1586/eri.11.103. Review.

PMID:
21973299
10.

Emergence and spread of drug resistant Neisseria gonorrhoeae.

Deguchi T, Nakane K, Yasuda M, Maeda S.

J Urol. 2010 Sep;184(3):851-8; quiz 1235. doi: 10.1016/j.juro.2010.04.078. Review.

PMID:
20643433
11.

Identification of amino acids conferring high-level resistance to expanded-spectrum cephalosporins in the penA gene from Neisseria gonorrhoeae strain H041.

Tomberg J, Unemo M, Ohnishi M, Davies C, Nicholas RA.

Antimicrob Agents Chemother. 2013 Jul;57(7):3029-36. doi: 10.1128/AAC.00093-13. Epub 2013 Apr 15.

12.

First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011.

Unemo M, Golparian D, Stary A, Eigentler A.

Euro Surveill. 2011 Oct 27;16(43). pii: 19998.

13.

Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Jul 8;60(26):873-7.

14.

Neisseria gonorrhoeae with reduced susceptibility to azithromycin--San Diego County, California, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 May 13;60(18):579-81.

15.

Does the '2012 IUSTI ECCG report on the diagnosis and management of Neisseria gonorrhoeae infections in Europe' depict the situation in Europe?

Unemo M, Brooks B, Cole M, Ross JD, White JA, Patel R; European Collaborative Clinical Group.

Int J STD AIDS. 2013 Jun;24(6):423-6. doi: 10.1177/0956462412473383. Epub 2013 Jul 10.

PMID:
23970742
16.

Quick recertification series. Gonorrhea.

Klingler A.

JAAPA. 2010 Nov;23(11):56. No abstract available.

PMID:
21086893
17.

Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010.

Martin I, Sawatzky P, Allen V, Hoang L, Lefebvre B, Mina N, Wong T, Gilmour M.

Sex Transm Dis. 2012 Apr;39(4):316-23. doi: 10.1097/OLQ.0b013e3182401b69.

PMID:
22421701
18.

Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.

Ison CA, Hussey J, Sankar KN, Evans J, Alexander S.

Euro Surveill. 2011 Apr 7;16(14). pii: 19833.

19.

Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden.

Golparian D, Hellmark B, Fredlund H, Unemo M.

Sex Transm Infect. 2010 Nov;86(6):454-60. doi: 10.1136/sti.2010.045377.

PMID:
20940159
20.

Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone.

Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, Nakayama S, Kitawaki J, Unemo M.

Antimicrob Agents Chemother. 2011 Jul;55(7):3538-45. doi: 10.1128/AAC.00325-11. Epub 2011 May 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk